Öz
Giriş: Nefrolitiyazis, hipertansiyonu olan hastalarda en sık görülen kronik böbrek hastalıklarından biridir. Bu çalışma, böbrek taşı hastalarının idrar örneklerinden Proteus mirabilis’i izole edip tanımlamayı, polimeraz zincir reaksiyonu (PCR) kullanarak ureC ve mrpA genlerinin varlığını araştırmayı ve bu hastalardaki TNF-α, IL-6 ve CCL2 düzeylerini değerlendirmeyi amaçlamıştır.
Gereç ve Yöntem: Mart 2025 ile Kasım 2025 sonu arasında Bağdat Valiliği’ndeki Bağdat Eğitim Hastanesi Üroloji bölümünden 50 idrar örneği alınmıştır. Ayrıca, çalışmaya kontrol grubu olarak 20 sağlıklı birey dahil edilmiştir. TNF-α, IL-6 ve CCL2 düzeylerinin incelenmesi amacıyla hastalardan ve kontrol grubundan kan örnekleri alınmıştır.
Bulgular: Çalışma sonuçları, en sık görülen bakterinin Proteus mirabilis olduğunu (10 olguda, %20) ve bunu her biri 7 olguda (%14) tespit edilen Escherichia coli ile Staphylococcus aureus’un izlediğini göstermiştir. Pseudomonas aeruginosa 6 olguda (%12), Klebsiella pneumoniae ise 5 olguda (%10) tespit edilmiştir. ureC ve mrpA genlerini hedef alan PCR tabanlı moleküler analizler, örneklerin %70’inde ureC, %60’ında ise mrpA geninin bulunduğunu ortaya koymuştur. Mevcut araştırma, böbrek taşı hastalarında TNF-α, IL-6 ve CCL2 düzeylerinin arttığını göstermiştir.
Sonuç: Bu araştırma, böbrek taşı olan hastalarda baskın bakterinin Proteus mirabilis olduğunu ortaya koymuştur. Sonuçlar, Proteus mirabilis’in bakterinin patojenitesine katkıda bulunan ureC ve mrpA genlerini taşıdığını göstermektedir. Ayrıca çalışma, böbrek taşı hastalarında TNF-α, IL-6 ve CCL2 düzeylerinde artış olduğunu ortaya koymuştur.
Anahtar Kelimeler: IL-6, böbrek taşı, mrpA, Proteus mirabilis, TNF-α, ureC, virülans genleri
Kaynakça
Elgendy AM, Nabil ZI, Gad El-Hak HN, Nafie MS, El-Shenawy NS. A review of types, mechanisms, complications, and management of renal stone formation. EAJBSC. 2024;16:313-21.
Skolarikos A, Geraghty R, Somani B, Tailly T, Jung H, Neisius A, Petřík A, Kamphuis GM, Davis N, Bezuidenhout C, Lardas M, Gambaro G, Sayer JA, Lombardo R, Tzelves L. European Association of Urology guidelines on the diagnosis and treatment of urolithiasis. Eur Urol. 2025;88:64-75.
Stamatelou K, Goldfarb DS. Epidemiology of kidney stones. Healthcare (Basel). 2023;11:424.
Peerapen P, Thongboonkerd V. Kidney stone prevention. Adv Nutr. 2023;14:555-56.
Xie B, Halter TJ, Borah BM, Nancollas GH. Aggregation of calcium phosphate and oxalate phases in the formation of renal stones. Cryst Growth Des. 2015;15:204-11.
El-Shimy A, Omran A, El-Tair E, Mohamed HI, Kamel I. Identification of different bacterial species isolated from infected renal stones and evaluation of its uricolytic activity. J Med Sci Res. 2018;1:Article 7.
Barbarossa A, Rosato A, Tardugno R, Carrieri A, Corbo F, Limongelli F, Fumarola L, Fracchiolla G, Carocci A. Antibiofilm effects of plant extracts against Staphylococcus aureus. Microorganisms. 2025;13:454.
Kulkarni SR, Peerapur BV, Sailesh KS. Isolation and antibiotic susceptibility pattern of Escherichia coli from urinary tract infections in a tertiary care hospital of North Eastern Karnataka. J Nat Sci Biol Med. 2017;8:176-80.
Wang Z, Zhang Y, Zhang J, Deng Q, Liang H. Recent advances on the mechanisms of kidney stone formation (Review). Int J Mol Med. 2021;48:149.
Sun Y, Wen S, Zhao L, Xia Q, Pan Y, Liu H, Wei C, Chen H, Ge J, Wang H. Association among biofilm formation, virulence gene expression, and antibiotic resistance in Proteus mirabilis isolates from diarrhetic animals in Northeast China. BMC Vet Res. 2020;16:176.
Chakkour M, Hammoud Z, Farhat S, El Roz A, Ezzeddine Z, Ghssein G. Overview of Proteus mirabilis pathogenicity and virulence. Insights into the role of metals. Front Microbiol. 2024;15:1383618.
Hussein EI, Al-Batayneh K, Masadeh MM, Dahadhah FW, Al Zoubi MS, Aljabali AA, Alzoubi KH. Assessment of pathogenic potential, virulent genes profile, and antibiotic susceptibility of Proteus mirabilis from urinary tract infection. Int J Microbiol. 2020;2020:1231807.
Elhoshi M, El-Sherbiny E, Elsheredy A, Aboulela AG. A correlation study between virulence factors and multidrug resistance among clinical isolates of Proteus mirabilis. Braz J Microbiol. 2023;54:1387-97.
El-Tarabili RM, Ahmed EM, Alharbi NK, Alharbi MA, AlRokban AH, Naguib D, Alhag SK, El Feky TM, Ahmed AE, Mahmoud AE. Prevalence, antibiotic profile, virulence determinants, ESBLs, and non-β-lactam encoding genes of MDR Proteus spp. isolated from infected dogs. Front Genet. 2022;13:952689.
Nzakizwanayo J, Pelling H, Milo S, Jones BV. An in vitro bladder model for studying catheter-associated urinary tract infection and associated analysis of biofilms. Methods Mol Biol. 2019;2021:139-58.
Al-Obaidi SA, Al-Hashimy AB. Molecular detection of (ureC, mrpA, hpmA) genes in Proteus mirabilis bacteria isolated from patients with urinary tract infection. Egypt J Hosp Med. 2023;90:716-20.
Aminsharifi A, Molaie A, Monsef A. Laparoscopic ın situ dismembered pyeloplasty can facilitate laparoscopic ureteropelvic junction obstruction repair: a prospective cohort trial. J Endourol. 2018;32:218-22.
Wang B, Tan Z, She W, Wang X, Guan X, Tao Z, Guo F, Xu H, Deng Y. Characterizing chemokine signaling pathways and hub genes in calcium oxalate-induced kidney stone formation: insights from rodent models. Biochem Genet. 2026;64:430-45.
Ni WF, Qin CC. Roles of chemokines in pancreatitis: a review. World J Gastrointest Pathophysiol. 2025;16:111550.
Liu Y, Sun Q, Long H, Qiu Z, Zhang D, Zhang H, Chen J. The value of IL-6, PCT, qSOFA, NEWS, and SIRS to predict septic shock after Percutaneous nephrolithotomy. BMC Urol. 2024;24:116.
Wahid RM, Hassan NH, Samy W, Faragallah EM, El-Malkey NF, Talaat A, Ghoneum A, Aldisi D, Malek MM. The protective effect of allium cepa against ethylene glycol-induced kidney stones in rats. Heliyon. 2023;9:e21221.
Suen JL, Liu CC, Lin YS, Tsai YF, Juo SH, Chou YH. Urinary chemokines/cytokines are elevated in patients with urolithiasis. Urol Res. 2010;38:81-7.
Tavichakorntrakool R, Prasongwattana V, Sungkeeree S, Saisud P, Sribenjalux P, Pimratana C, Bovornpadungkitti S, Sriboonlue P, Thongboonkerd V. Extensive characterizations of bacteria isolated from catheterized urine and stone matrices in patients with nephrolithiasis. Nephrol Dial Transplant. 2012;27:4125-30.
Al-Bassam WW, Al-Kazaz AK. The isolation and characterization of Proteus mirabilis from different clinical samples. J Biotechnol Res Cent. 2013;7:24-30.
Shareef YH, Najem QT, Muhammad JZ. Molecular detection of adhesion genes of Proteus mirabilis isolated from UTI Iraqi patients with kidney stones. MJBU. 2024;42:e185804.
Mahmood AA, Qadir MB, Muhammad AJ, Abdulla TH, Thomas VN, Diyya SMA. Community-acquired infection among the hospitalized renal stone patients. J Health Allied Sci NU. 2024;14:523-6.
Liu F, Zhang N, Jiang P, Zhai Q, Li C, Yu D, Wu Y, Zhang Y, Lv L, Xu X, Feng N. Characteristics of the urinary microbiome in kidney stone patients with hypertension. J Transl Med. 2020;18:130.
Maione A, Galdiero E, Cirillo L, Gambino E, Gallo MA, Sasso FP, Petrillo A, Guida M, Galdiero M. Prevalence, resistance patterns and biofilm production ability of bacterial uropathogens from cases of community-acquired urinary tract infections in South Italy. Pathogens. 2023;12:537.
Nathaniel E, Ikram J, James A, Obaid B, Zahid A, Ahmed Z, Wazir DK, Muhammad Farooq Wahab Q, Varrassi G, Kumar S, Khatri M. Retraction: molecular characterization and antibiotic susceptibility pattern of bacterial strains isolated from wound of patients with diabetes. Cureus. 2024;16:r138.
Hameed Mustafa A. Molecular characterization of multidrug-resistant Proteus mirabilis isolates from pregnant women with recurrent urinary tract infection in Erbil city, Iraq. Iran J Microbiol. 2025;17:751-60.
Li Y, Yin M, Fang C, Fu Y, Dai X, Zeng W, Zhang L. Genetic analysis of resistance and virulence characteristics of clinical multidrug-resistant Proteus mirabilis isolates. Front Cell Infect Microbiol. 2023;13:1229194.
Wang J, Wang W, Guo W, Ma Y, Ji T, Zhang B. Clinical importance of chemokines and inflammatory cytokines for patient care following percutaneous nephrolithotripsy. Exp Ther Med. 2018;15:2189-95.
Xiang L, Zhou D, Zhang H, Li P, Zhou X. Changes of serum and urine cytokines of patients with infectious kidney stones. Chin J Nosocomiol. 2017;27:5172-5.
Sun AY, Hinck B, Cohen BR, Keslar K, Fairchild RL, Monga M. Inflammatory cytokines in the papillary tips and urine of nephrolithiasis patients. J Endourol. 2018;32:236-44.
Budak D, Yilmaz VT, Akbas H, Suleymanlar G, Yucel G. Association between graft function and serum TNF-α, TNFR1 and TNFR2 levels in patients with kidney transplantation. Ren Fail. 2015;37:871-6.
Ahuja N, Andres-Hernando A, Altmann C, Bhargava R, Bacalja J, Webb RG, He Z, Edelstein CL, Faubel S. Circulating IL-6 mediates lung injury via CXCL1 production after acute kidney injury in mice. Am J Physiol Renal Physiol. 2012;303:F864-72.
Kang DH, Rice M, Park NJ, Turner-Henson A, Downs C. Stress and inflammation: a biobehavioral approach for nursing research. West J Nurs Res. 2010;32:730-60.
Boonla C, Hunapathed C, Bovornpadungkitti S, Poonpirome K, Tungsanga K, Sampatanukul P, Tosukhowong P. Messenger RNA expression of monocyte chemoattractant protein-1 and interleukin-6 in stone-containing kidneys. BJU Int. 2008;101:1170-7.
Abd-Alwahab WI, Ajeel AA, Al-Dulaimi FK. The important correlating role of some cytokines with kidney stones in renal calculi patients. AIP Conf Proc. 2022;2394:020012.
Taguchi K, Okada A, Unno R, Hamamoto S, Yasui T. Macrophage function in calcium oxalate kidney stone formation: a systematic review of literature. Front Immunol. 2021;12:673690.


